Endocrine case study. Diagnosis: Severe Anxiety and Hyperthyroidism.
Patient: Sarah Miller
Age: 32 years old
Diagnosis: Severe Anxiety and Hyperthyroidism
SUBJECTIVE
HPI
Sarah Miller is a 32-year-old female presenting to the primary care clinic with complaints of severe anxiety, palpitations, and weight loss over the past two months. She describes feeling constantly on edge, experiencing episodes of intense fear, and having difficulty sleeping. Sarah also reports increased sweating, tremors, and frequent bowel movements. She has a history of anxiety but notes that her symptoms have significantly worsened recently. Sarah denies any recent illness or significant life changes that might explain the exacerbation of her anxiety.
ROS
General: Reports significant weight loss and increased sweating. No recent fever.
Cardiovascular: Reports palpitations and chest discomfort. No history of edema.
Respiratory: Denies shortness of breath or cough.
Gastrointestinal: Reports frequent bowel movements. Denies nausea or vomiting.
Genitourinary: Denies dysuria or hematuria.
Neurological: Reports tremors and difficulty concentrating. Denies focal neurological deficits or seizures.
Musculoskeletal: Denies joint pain or muscle weakness.
Endocrine: Reports heat intolerance, weight loss, and increased sweating.
Psychiatric: Reports severe anxiety and insomnia. Denies depression or suicidal thoughts.
PMH
Generalized anxiety disorder
No known thyroid disease
SURGICAL HISTORY
None
FAMILY HISTORY
Father: Alive, age 60, history of hypertension
Mother: Alive, age 58, history of hyperthyroidism
Siblings: One brother, age 35, healthy
SOCIAL HISTORY
Occupation: Marketing Manager
Marital Status: Single
Tobacco Use: None
Alcohol Use: Socially
Illicit Drug Use: Denies
Diet: Balanced diet, adequate nutrition
Exercise: Irregular due to recent symptoms
MEDICATION
Sertraline for anxiety
ALLERGIES
None
OBJECTIVES
VITAL SIGNS
Blood Pressure: 140/90 mmHg
Heart Rate: 110 bpm
Respiratory Rate: 20 breaths/min
Temperature: 99.5°F
SpO2: 98% on room air
BMI: 22 kg/m²
PHYSICAL EXAM
General: Well-nourished, well-developed female in mild distress due to anxiety.
HEENT: Normocephalic, atraumatic. Enlarged thyroid, no thyroid nodules.
Cardiovascular: S1 and S2 normal. Tachycardia without murmurs, rubs, or gallops. Capillary refill <2 seconds.
Respiratory: Clear to auscultation bilaterally. No wheezes, crackles, or rhonchi.
Gastrointestinal: Abdomen soft, non-tender, no hepatosplenomegaly. Bowel sounds normal.
Neurological: Alert and oriented x3. Tremors present. Cranial nerves II-XII intact. No focal deficits.
Musculoskeletal: Full range of motion in all extremities. No joint swelling or tenderness.
Skin: Warm, moist skin. No rashes or lesions.
TSH: 0.2 mIU/L and Free T45 ng/ dl
T4: 15
Assessment
Hyperthyroidism
Severe anxiety
Tachycardia
Weight loss
Case Study Analysis for Sarah Miller's Hyperthyroidism Management
Student
Instructor
Institution
Course and Code
Date
Case Study Questions
What are the first-line pharmacological treatment options for this case? Provide a detailed explanation of why each medication is appropriate.
Answer
Methimazole (15-30 mg daily) is the first-line antithyroid drug. The drug is appropriate as it specifically addresses the biochemical imbalances in Sarah, consisting of raised T4 (15 ng/dl) and suppressed TSH (0.2 mIU/L) by blocking the thyroid peroxidase enzyme, interfering with the synthesis of thyroid hormone at the core cause level (Gill, 2024). This specificity makes methimazole the best option to treat the underlying cause of Sarah's symptoms. Its once-daily dosing will facilitate adherence due to Sarah's rigorous marketing career, and its excellent safety profile compared to that of propylthiouracil makes it ideal as far as this age group is concerned.
Propranolol (20-40 mg twice daily) is a vital add-on first-line treatment. This beta blocker is suitable since it addresses explicitly cardiovascular manifestations that affect Sarah, such as tachycardia (110 bpm), hypertension (140/90 mmHg), palpitations, and neuro-oriented findings, including tremors and anxiety. It can penetrate the CNS, which suppresses symptoms in a short period when compared to methimazole, which takes weeks to reach therapeutic levels (Mooij et al., 2022). Combining two approaches can guarantee immediate relief of the symptoms and long-term disease control.
What alternative medications could be considered if the first-line treatments are not effective or suitable? Justify your rationale for each alternative.
Answer
Propylthiouracil (PTU) (100).-150 mg three times daily serves as the primary alternative if methimazole causes adverse reactions. PTU is justified because it provides dual mechanism action - inhibiting thyroid hormone synthesis and peripheral T4-to-T3 conversion, which can benefit severe thyrotoxicosis like Sarah's case (Kim, 2023). This dual action makes PTU particularly valuable when rapid control of thyroid hormone levels is essential.
Radioactive Iodine (RAI) therapy represents a definitive alternative for patients preferring permanent treatment. This option is justified by its 90% cure rate with a single treatment, making it appropriate if Sarah experiences medication intolerance or desires definitive therapy without long-term medication use (Gill, 2024). This definitive approach eliminates the need for prolonged antithyroid medication use while providing permanent resolution of hyperthyroidism.
Atenolol (25-50 mg daily) offers an alternative beta-blocker if propranolol causes adverse effects. Its cardioselective effect is only reasonable amongst individuals with propranolol-induced bronchospasm and individuals with inappropriate fatigue that might impair work performance (Gill, 2024). This selective beta-1 blockade balances the cardiovascular benefits with the opportunity to alleviate undesired consequences on respiratory and metabolic functions.
Why did you choose the specific drug(s) for this patient? Explain how they align with the patient's clinical presentation.
Answer
Methimazole selection directly aligns with Sarah's laboratory findings, showing primary hyperthyroidism requiring antithyroid medication. She is aged (32 years), not pregnant, and her occupation as a marketing manager is demanding, requiring once-daily dosing to help with her adherence. The drug directly addresses the biochemical disturbances that lead to her weight loss, palpitations, and anxiety complaints.
Propranolol selection specifically targets Sarah's multi-system presentation, including cardiovascular symptoms (tachycardia, hypertension, palpitations) and neurological manifestations (tremors, anxiety). Her work-related stress combined with hyperthyroid-induced anxiety necessitates rapid symptom control, which propranolol's immediate action provides, while methimazole achieves long-term therapeutic effects.
What non-pharmacological strategies would you recommend for this patient? Be specific in your suggestions.
👀 Other Visitors are Viewing These APA Essay Samples:
-
Mentor Interview
2 pages/≈550 words | No Sources | APA | Health, Medicine, Nursing | Coursework |
-
Strategic Risks
1 page/≈275 words | 2 Sources | APA | Health, Medicine, Nursing | Coursework |
-
Study guide
4 pages/≈1100 words | No Sources | APA | Health, Medicine, Nursing | Coursework |